Skip to content

Clinical trials

Phase 2 Lymphoma, Mantle-Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 2 Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20071
20091
20101
20122
20131
20191
20213
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NCIC Clinical Trials Group4
Alliance for Clinical Trials in Oncology3
AstraZeneca2
Canadian Cancer Trials Group1
Cephalon1
Eastern Cooperative Oncology Group1
Gilead Sciences1
Merck Sharp & Dohme LLC1
Miltenyi Biomedicine GmbH1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell19
Lymphoma10
Lymphoma, Follicular7
Lymphoma, Large B-Cell, Diffuse5
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, B-Cell3
Lymphoma, Non-Hodgkin3
Burkitt Lymphoma2
Lymphoma, Large-Cell, Immunoblastic2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.